Belvedere Trading LLC Vaxcyte, Inc. Put Options Transaction History

Belvedere Trading LLC

  • $74.4 Billion
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Oct 30, 2024
SELL
$70.52 - $117.12 $705,200 - $1.17 Million
-10,000 Reduced 79.37%
2,600 $296,000
Q2 2024

Nov 01, 2024
BUY
$60.06 - $78.77 $600,600 - $787,700
10,000 Added 384.62%
12,600 $951,000
Q2 2024

Aug 09, 2024
BUY
$60.06 - $78.77 $78,078 - $102,401
1,300 Added 11.5%
12,600 $951,000
Q1 2024

May 09, 2024
BUY
$59.79 - $81.05 $675,627 - $915,865
11,300 New
11,300 $771,000

Others Institutions Holding PCVX

# of Institutions
354
Shares Held
122M
Call Options Held
775K
Put Options Held
433K
View Full List

About Vaxcyte, Inc.

PCVX Quotes by TradingView
  • Ticker PCVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,315,100
  • Market Cap $5.03B
  • Description
  • Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...
More about PCVX
Track This Portfolio

Track Belvedere Trading LLC Portfolio

Follow Belvedere Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belvedere Trading LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email